KU
Kuros Biosciences AG
KURN.SW · SIX
CHF 18.91 -1.87% (-CHF 0.36)
1M -13.97%
Market Cap CHF 763.2M
P/E Ratio 360.22x
Div. Yield -
ROE 3.09%
Bulios Fair Price
CHF 9.58
49.3% downside
Trenutna cena
CHF 18.91
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica KURN.SW trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
3 /100
Expensive P/E 360.22x
EV/EBITDA 74.19x
P/B 11.40x
Growth
82 /100
Growing Rev. growth 88.93%
Book val. growth 0.94%
EPS growth N/A
Profitability
31 /100
Weak Gross margin 86.39%
Net margin 1.75%
FCF margin 1.98%
Quality
30 /100
Poor ROIC 4.84%
ROE 3.09%
Asset turnover 1.13x
Debt
100 /100
Low Debt/Equity 0.06x
Current ratio 1.96x
Net debt/EBITDA -1.16x
Stability
39 /100
Moderate Beta 0.76x
Rev. volatility 32.48%
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o KURN.SW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher T. Fair
Employees
178
Headquarters
Schlieren
Prihajajoči dogodki
17 MAR.
Earnings
Upcoming earnings report